Similar medications and substitutes for NIVOLUMAB AND HYALURONIDASE-NVHY
In short: Opdivo Qvantig (NIVOLUMAB AND HYALURONIDASE-NVHY) belongs to the Programmed Death Receptor-1 Blocking Antibody class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Opdivo Qvantig is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Opdivo Qvantig in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.